Comparative safety and effectiveness of tumor necrosis factor α antagonists and vedolizumab in elderly IBD patients: A multicenter study

BACKGROUND: The older patient with inflammatory bowel diseases (IBD) is particularly vulnerable to consequences of disease and therapy-related side effects but little is known about the best treatment options in this population. AIM: To compare safety and efficacy of tumor necrosis factor α antagoni...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Aliment Pharmacol Ther
Autori principali: Adar, Tomer, Faleck, David M., Sasidharan, Saranya, Cushing, Kelly, Borren, Nienke Z, Nalagatla, Niharika, Ungaro, Ryan C., Wayne, Sy, Samuel C, Owen, Patel, Anish, Cohen, Benjamin L., Ananthakrishnan, Ashwin N
Natura: Artigo
Lingua:Inglês
Pubblicazione: 2019
Soggetti:
Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC6423511/
https://ncbi.nlm.nih.gov/pubmed/30773667
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/apt.15177
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi